Omada Health

Omada Health

OMDA
Omada HealthUS flagNASDAQ Global Market
19.66
USD
+0.32
- -
1.20BMarket Cap
Omada Health
OMDA
(NASDAQ Global Market)

Recent

price

19.66

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
TTM
FRC
1.87
2.57
3.05
7.1
5.29
Revenue per Share
-1.52
-1.41
-0.85
-0.35
0.07
Basic EPS, GAAP
-1.5
-1.1
-0.68
0.46
0.39
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
-5.26
-6.28
-14.95
3.93
4.17
Book Value per Share
-5.65
-6.63
-15.27
3.66
3.93
Tangible Book Value per Share
48
48
56
37
59
Basic Weighted Avg Shares
89
123
170
260
310
Sales/Revenue/Turnover
-81.12
-53.75
-25.71
-4.6
-0.15
Operating Margin (%)
4
4
5
5
6
Depreciation Expense
-73
-68
-47
-13
4
Net Income, GAAP
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-81.31
-54.98
-27.76
-4.91
1.39
Profit Margin (%)
154
99
59
197
219
Working Capital
30
30
30
- -
- -
LT Debt
156
99
-384
230
253
Total Equity
- -
- -
- -
- -
-0.19
Return on Invested Capital (%)
- -
- -
- -
- -
1.89
Return on Capital (%)
- -
- -
- -
- -
1.84
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
58
59
61
Market Capitalization
922
745
1,330

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
273
269
295
Cash, Cash Equivalents & STI
222
212
222
Accounts Receivable, Net
14
14
32
Inventories
4
4
4
Total Current Liabilities
76
69
75
Payables & Accruals
26
39
48
ST Debt
- -
- -
- -
Deferred Revenue
25
29
28

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-159.75%
Free Cash Flow
- -
- -
-144.5%
Net Income, GAAP
- -
- -
-72.89%
Sales/Revenue/Turnover
- -
- -
53.24%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
35
41
- -
- -
170
2025
55
61
68
76
260
2026
78
88
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.4
-0.22
- -
- -
-0.85
2025
-0.17
-0.24
-0.06
0.09
-0.35
2026
-0.05
0.09
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Omada Health Omada Health, Inc. provides virtual care programs focused on chronic condition management in the United States; its core offerings include cardiometabolic programs for prediabetes, diabetes, hypertension, and weight management with personalized health coaching, connected devices such as scales, blood pressure monitors, and glucose meters, interactive lessons, peer communities, and virtual physician support; musculoskeletal programs addressing joint and muscle conditions through physical therapy; behavioral health support; and integrated care for members using glucagon-like peptide-1 agonists. The company serves employers, health plans, pharmacy benefit managers, and health systems via direct sales and channel partners, operating primarily from its San Francisco, California headquarters where it was founded in 2011. Recent developments encompass its June 2025 initial public offering on Nasdaq under ticker OMDA raising approximately $150 million, partnerships including Amazon Health Condition Programs launched in 2024 and collaborations with Cigna, nationwide prescribing capability for anti-obesity medications announced in 2025, the 2020 acquisition of Physera to expand musculoskeletal services, and URAC accreditation for MSK care plus NCQA accreditation for diabetes programs achieved in recent years.

Company News

  • Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress

  • Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026

  • Reviewing HCA Healthcare (NYSE:HCA) & Omada Health (NASDAQ:OMDA)

  • Omada Health, Inc. (NASDAQ:OMDA) Stock Has Average Price Target of $26.67

  • Bank of America Corp DE Acquires 313,440 Shares of Omada Health, Inc. $OMDA

  • Omada Health (NASDAQ:OMDA) and NeoGenomics (NASDAQ:NEO) Head-To-Head Contrast

  • Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000

  • Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript

  • Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day

  • Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program

  • Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares

  • Omada Health, Inc. (NASDAQ:OMDA) Receives $26.50 Average PT from Brokerages

  • 2,222,074 Shares in Omada Health, Inc. $OMDA Bought by BlackRock Inc.

  • Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings

  • Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

  • Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

  • Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

  • Omada Health Q2 Earnings Call Highlights

  • Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates

  • Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition